Mini Ibovespa - Outubro 2025 (WINV25) 뉴스

EL-22 has also completed a Phase 1 clinical trial in South Korea, where it was shown to be generally well tolerated and safe in healthy volunteers.

That's based on a sp of $.000001. At $.0001, your stock is worth $5,200. That's a little better. But what you'll eventually be able to sell it for once it gets off the Expert Market and the R/S takes place so trading can resume is the question.

😀😃😄😁😆😅🤣😂

AABB has lied about what the plant costs. Whoever it belongs to.

Always...

1) The May 2024 ASM presentation clearly showing the 4x200 PIC was IN QUALIFICATIONS on Slide 29, that is 100% FACT

2) KCC's post revealing that investors learned that 4x200 PIC was being SHIPPED TO CUSTOMERS (obviously for Qualifications based on Slide 29 showing the 4x200 PIC was IN

Vess be holding long teurm...

Yes you're doing great and it's great you keep trying!!!!! GREAT JOB!!!!!!!

That autopsy on Eddie's lies is nearly 15 years old which speaks volumes to any sane, rational person. He's only gotten worse over time which has made anything associated with him radioactive.

http://quicktraders.blogspot.com/2010/02/you-cant-judge-book-by-its-cover-part.html

A taking without compensation is NOT permitted or protected by HERA because it's unconstitutional.

HERA

The court of appeals acknowledged that Section
4617(f)’s bar on judicial intervention does not apply
when FHFA “has acted or proposes to act beyond, or

I listened to that interview years ago!! Everything's corrupt but you still have to play the game!!

So I have two new plays going into my long term portfolio for the next 4 years.
Drill baby Drill- $PHX-Phx Minerals Class A- $.16 dividend per year
Semiconductors- $TOYO- Toyo Co LTD- The Japanese have always done technology right.

My guess, it would be announced after the current Director has left that position.

Blah, Blah, Blah...
"any child will tell you that the PAA has been finalized.."

SHOW a document that states what YOU PROCLAIN to be true.
Put up or ... you know the thing...

"do me a favor... dont address any more posts to me..."

How about

How hysterical

..... it's REVOKED

I'll answer for him since you keep spouting this nonsense about tumor response. Yes, it is common for immunotherapies to use ORR in combination with DOR. RMAT trials are often based on ORR in a line where there are no approved therapies. SMFH, you are rookie a biotech investor, but an expert d

No he hasn't. They had a 10:1 split in 2009.

Surely you know the difference between a split and issuing shares.

https://valueofstocks.com/2022/06/18/share-dilution-vs-stock-split/

Free Fiddy!!

Thanks. I just keep trying and trying 

Query OTC Markets 2x a day

This is just my opinion based on years of experience in investing and a decent amount in Biotech. There's NO WAY any serious researcher with respect for themselves would ever start posting on a board like this. Anyone posting critical write ups on a message board like this are doing so for purely fi

BIEL: BUY RATING
https://www.barchart.com/stocks/quotes/BIEL/opinion

BIEL: BUY RATING
https://www.barchart.com/stocks/quotes/BIEL/opinion